Susan J. Boorin, PhD, MSN, PMHNP-BC
Director of Clinical Education YSN Online PMHNP Program
email: susan.boorin@yale.edu
phone: 203-737-4902
About
Susan J. Boorin, PhD, MSN, PMHNP-BC, is a Senior Lecturer in the Psychiatric Mental Health Nurse Practitioner (PMHNP) program and Director of Clinical Education for the Yale School of Nursing (YSN) Hybrid/Online PMHNP program. In this role, Dr. Boorin has developed and expanded partnerships between YSN and clinical agencies in the community and across the country. Her teaching focuses on psychopharmacology and psychopathology, with particular expertise in child and adolescent mental health.
Dr. Boorin earned her MSN from Hunter College, City University of New York, where she received the Dean’s Award for Outstanding Graduate Student and served as the 1992 class commencement speaker. She completed a post-master’s certificate at Yale School of Nursing and earned her PhD from Yale in 2013, receiving the Anthony DiGuida Delta Mu Research Prize in Nursing.
Clinical Practice
Dr. Boorin has worked in both outpatient and inpatient mental health settings in New York and Connecticut for several decades, with experience ranging from acute psychiatric ICU units to community-based outpatient care. She is the owner of Psychiatric Health Associates, LLC, a nurse-owned private practice on the Milford Green that she founded in 2014. The practice provides outpatient psychiatric services across the lifespan and is grounded in the belief that the therapeutic alliance between patient and provider is a catalyst for change.
Research Interests
Dr. Boorin’s scholarly work focuses on child mental health. Her master’s thesis, The Relationship of Self-Esteem and Locus of Control for the Hospitalized Child Psychiatric Client, received the Shuster Award for Outstanding Thesis. During her doctoral training at Yale, she contributed to research at the Yale Child Study Center on autism, parent training, psychopharmacology, and cardiometabolic monitoring in children treated with psychiatric medication. Her dissertation, Cardiometabolic Side Effects of Risperidone in Children with Autism, examined metabolic outcomes associated with risperidone treatment in pediatric autism.
Selected Publications/Presentations
Frankel, H. & Boorin, S. (2023). The Impact of Length of MAT Treatment on Opioid Abstinence. APNA 37th Annual Conference Psychiatric-Mental Health Nurses: Novel IDEAS Moving Whole Health Forward, Orlando, Florida.
Poster Presentation
Boorin, S. & Keltner, N. (2021). Neurobiology and neurophysiology of behavioral/psychiatric disorders. In Yearwood, E.L., Pearson, G.S. & Newland, J.A. Child and Adolescent Behavioral Health: A Resource for Advanced Psychiatric and Primary Care Practitioners in Nursing, 2nd Ed. Wiley-Blackwell: Iowa.
Boorin, S. (2020). Antipsychotics (2nd edition). In Volkmar, F. Editor in Chief, Encyclopedia of Autism Spectrum Disorders. Springer: New York.
Scahill, L., Jeon, S., Boorin, S. J., McDougle, C. J., Aman, M. G., Dziura, J., … Vitiello, B. (2016). Weight Gain and Metabolic Consequences of Risperidone in Young Children with Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 55(5), 415-423. DOI: 10.1016/j.jaac.2016.02.016
Boorin, S. (September 14, 2012). Cardiometabolic Side Effects of Risperidone in Children with
Autism. State of the Science Congress on Nursing Research, Washington D.C.
Oral presentation of research results.
Scahill, L. & Boorin, S. (2011). Psychopharmacology in children with PDD: Review of current evidence. In Reichow, B., Doehring, P., Cicchetti, D. & Volkmar, F. (Eds.). Evidence-based practices treatments for children with autism. Springer: New York.